Home/Filings/4/0001104659-25-114081
4//SEC Filing

ELMS STEVE 4

Accession 0001104659-25-114081

CIK 0001094038other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:01 PM ET

Size

8.5 KB

Accession

0001104659-25-114081

Insider Transaction Report

Form 4
Period: 2025-11-17
ELMS STEVE
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-11-17+84,41184,411 total
    Exercise: $0.95Exp: 2035-11-17Common Stock (84,411 underlying)
  • Award

    Stock Option (right to buy)

    2025-11-17+137,330137,330 total
    Exercise: $0.95Exp: 2035-11-17Common Stock (137,330 underlying)
Footnotes (2)
  • [F1]Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan for the remaining options due as service as a director for the year 2024. 30,000 shares were previously granted on February 12, 2025. The options vest on the anniversary of the grant date. The option exercise price is the closing price on the date of the grant, November 17, 2025.
  • [F2]Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan for service as a director for the year 2025. The options vest on the anniversary of the grant date. The option exercise price is the closing price on the date of the grant, November 17, 2025.

Issuer

Marker Therapeutics, Inc.

CIK 0001094038

Entity typeother

Related Parties

1
  • filerCIK 0001250195

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:01 PM ET
Size
8.5 KB